By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Accelrys reported after the close of the market on Monday a 70 percent jump year over year in second-quarter revenues.

For the three months ended June 30, the San Diego-based firm posted $33.7 million in revenues, up from $19.8 million a year ago. The increase was led by license and subscription revenues, which climbed to $18.6 million, a 21 percent increase, while maintenance on perpetual licenses jumped 258 percent to $8.6 million from $2.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.